{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:13:24Z","timestamp":1770239604606,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09635-4","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:59:44Z","timestamp":1747177184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of antipsoriatic potential of novel pemetrexed disodium\u2013loaded transdermal patches in an imiquimod-induced mouse model"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-6127","authenticated-orcid":false,"given":"Tejpal","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-7095","authenticated-orcid":false,"given":"Hemant Kumar Singh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-4886","authenticated-orcid":false,"given":"Ritu","family":"Gilhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"9635_CR1","doi-asserted-by":"crossref","unstructured":"Sermsaksasithorn P, Asawanonda P, Phutrakool P, Ondee T, Chariyavilaskul P, Payungporn S, et al. Efficacy and safety of cannabis transdermal patch for alleviating psoriasis symptoms: protocol for a randomized controlled trial (CanPatch). Med Cannabis Cannabinoids [Internet]. 2024 [cited 2024 Dec 26]; Available from: https:\/\/karger.com\/doi\/10.1159\/000539492","DOI":"10.1159\/000539492"},{"key":"9635_CR2","doi-asserted-by":"crossref","unstructured":"Yadav T, Yadav HKS, Raizaday A, Alam MS. The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: a new approach. BioImpacts [Internet]. 2024 [cited 2024 Dec 17]; Available from: https:\/\/bi.tbzmed.ac.ir\/Inpress\/bi-30341.pdf","DOI":"10.34172\/bi.30341"},{"key":"9635_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/polym14071310","volume":"14","author":"MS Latif","year":"2022","unstructured":"Latif MS, Al-Harbi FF, Nawaz A, Rashid SA, Farid A, Mohaini MA, et al. formulation and evaluation of hydrophilic polymer based methotrexate patches: in vitro and in vivo characterization. Polymers. 2022;14:1310.","journal-title":"Polymers"},{"key":"9635_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118623","volume":"569","author":"M Bahramizadeh","year":"2019","unstructured":"Bahramizadeh M, Bahramizadeh M, Kiafar B, Jafarian AH, Nikpoor AR, Hatamipour M, et al. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm. 2019;569.","journal-title":"Int J Pharm"},{"key":"9635_CR5","doi-asserted-by":"publisher","first-page":"e0137890","DOI":"10.1371\/journal.pone.0137890","volume":"10","author":"YK Lin","year":"2015","unstructured":"Lin YK, Yang SH, Chen CC, Kao HC, Fang JY. Using imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugs. PLOS ONE. 2015;10:e0137890. https:\/\/doi.org\/10.1371\/journal.pone.0137890.","journal-title":"PLOS ONE"},{"key":"9635_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/0118715230320581240711063558","volume":"23","author":"R Yadav","year":"2024","unstructured":"Yadav R, Yadav T, Upadhayay A, Alam MdS, Dubey G, Kumar V, et al. The influence of phytoconstituents for the management of antipsoriatic activity in various animal models. Anti-Inflamm Anti-Allergy Agents Med Chem. 2024;23:215\u201329.","journal-title":"Anti-Inflamm Anti-Allergy Agents Med Chem"},{"key":"9635_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1208\/s12249-024-02781-2","volume":"25","author":"EZ Dahmash","year":"2024","unstructured":"Dahmash EZ, Attiany LM, Ali D, Assaf SM, Alkrad J, Alyami H. Development and characterization of transdermal patches using novel thymoquinone-l-arginine-based polyamide nanocapsules for potential use in the management of psoriasis. AAPS PharmSciTech. 2024;25:69.","journal-title":"AAPS PharmSciTech"},{"key":"9635_CR8","unstructured":"Pemetrexed - an overview | ScienceDirect Topics [Internet]. [cited 2024 Dec 27]. Available from: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/pemetrexed"},{"key":"9635_CR9","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-19-0433","volume":"25","author":"DA Schaer","year":"2019","unstructured":"Schaer DA, Geeganage S, Amaladas N, Lu ZH, Rasmussen ER, Sonyi A, et al. The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy. Clin Cancer Res. 2019;25:7175\u201388.","journal-title":"Clin Cancer Res"},{"key":"9635_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/cas.14401","volume":"111","author":"T Okimoto","year":"2020","unstructured":"Okimoto T, Kotani H, Iida Y, Koyanagi A, Tanino R, Tsubata Y, et al. Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells. Cancer Sci. 2020;111:1910\u201320.","journal-title":"Cancer Sci"},{"key":"9635_CR11","unstructured":"Claire R, Griffiths CE. Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol [Internet]. 2020 [cited 2024 Jan 28];100. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9128930\/"},{"key":"9635_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.1984.tb07309.x","volume":"110","author":"BS Baker","year":"1984","unstructured":"Baker BS, Swain AF, Valdimarsson H, Fry L. T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol. 1984;110:37\u201344.","journal-title":"Br J Dermatol"},{"key":"9635_CR13","doi-asserted-by":"crossref","unstructured":"Baker BS, Swain SF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. In: MacDonald DM, editor. Immunodermatology [Internet]. Butterworth-Heinemann; 1984 [cited 2025 Mar 5]. p. 183\u20134. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780407003385500478","DOI":"10.1016\/B978-0-407-00338-5.50047-8"},{"key":"9635_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/sonc.2002.37461","volume":"29","author":"ID Goldman","year":"2002","unstructured":"Goldman ID, Zhao R. Molecular, biochemical, and cellular pharmacology of pemetrexed. Semin Oncol. 2002;29:3\u201317.","journal-title":"Semin Oncol"},{"key":"9635_CR15","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/nano14211760","volume":"14","author":"AA Elkordy","year":"2024","unstructured":"Elkordy AA, Hill D, Attia M, Chaw CS. Liposomes and their therapeutic applications in enhancing psoriasis and breast cancer treatments. Nanomaterials. 2024;14:1760.","journal-title":"Nanomaterials"},{"key":"9635_CR16","unstructured":"Patel NS, Kilaru S, Thennati R. Stable amorphous form of pemetrexed disodium [Internet]. 2009 [cited 2025 Mar 5]. Available from: https:\/\/patents.google.com\/patent\/US20090181990A1\/en"},{"key":"9635_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1535-7163.MCT-06-0343","volume":"6","author":"S Chattopadhyay","year":"2007","unstructured":"Chattopadhyay S, Moran RG, Goldman ID. Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther. 2007;6:404\u201317.","journal-title":"Mol Cancer Ther"},{"key":"9635_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Boisgard A-S, Danoy A, El Kholti N, Salvi J-P, Boulieu R, et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics. 2020;12:789.","journal-title":"Pharmaceutics"},{"key":"9635_CR19","doi-asserted-by":"crossref","unstructured":"Li N, Qin Y, Dai D, Wang P, Shi M, Gao J, et al. Transdermal delivery of therapeutic compounds with nanotechnological approaches in psoriasis. Front Bioeng Biotechnol [Internet]. 2022 [cited 2024 Dec 27];9. Available from: https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/10.3389\/fbioe.2021.804415\/full","DOI":"10.3389\/fbioe.2021.804415"},{"key":"9635_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1208\/s12249-023-02595-8","volume":"24","author":"B Kumar","year":"2023","unstructured":"Kumar B, Sahoo PK. Augmented transdermal delivery of curcumin for the effective management of plaque psoriasis \u2013 design, formulation, characterisation, and in vivo studies. AAPS PharmSciTech. 2023;24:134.","journal-title":"AAPS PharmSciTech"},{"key":"9635_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics16010036","volume":"16","author":"I B\u00e1cskay","year":"2024","unstructured":"B\u00e1cskay I, Hossz\u00fa Z, Budai I, Ujhelyi Z, Feh\u00e9r P, K\u00f3sa D, et al. Formulation and evaluation of transdermal patches containing BGP-15. Pharmaceutics. 2024;16:36.","journal-title":"Pharmaceutics"},{"key":"9635_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/imm.13873","volume":"174","author":"M Xue","year":"2025","unstructured":"Xue M, Yang R, Li G, Ni Z, Chao Y, Shen K, et al. LGR4 deficiency aggravates skin inflammation and epidermal hyperplasia in imiquimod-induced psoriasis. Immunology. 2025;174:213\u201325.","journal-title":"Immunology"},{"key":"9635_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/0115672018246645231019131748","volume":"22","author":"S Vihal","year":"2025","unstructured":"Vihal S, Pundir S, Rathore C, Lal UR, Gupta G, Singh SK, et al. Nigella sativa oil-loaded ethanolic vesicular gel for imiquimod-induced plaque psoriasis: physicochemical characterization, rheological studies, and in vivo efficacy. Curr Drug Deliv. 2025;22:80\u201391.","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"9635_CR24","doi-asserted-by":"publisher","first-page":"14244","DOI":"10.1038\/s41598-022-18671-1","volume":"12","author":"H Jamshaid","year":"2022","unstructured":"Jamshaid H, Din FU, Malik M, Mukhtiar M, Choi HG, Ur-Rehman T, et al. A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice. Sci Rep. 2022;12(1):14244. https:\/\/doi.org\/10.1038\/s41598-022-18671-1.","journal-title":"Sci Rep"},{"issue":"2","key":"9635_CR25","first-page":"130","volume":"45","author":"H Fang","year":"2022","unstructured":"Fang H, Hou Y, Zhuang H, Wang C. The effects of Malassezia in the activation of Interleukin (IL)-23\/IL-17 axis in Psoriasis. New Microbiol. 2022;45(2):130\u20137.","journal-title":"New Microbiol"},{"key":"9635_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102458","volume":"63","author":"S Mittal","year":"2021","unstructured":"Mittal S, Ali J, Baboota S. Enhanced anti-psoriatic activity of tacrolimus loaded nanoemulsion gel via omega 3 - fatty acid (EPA and DHA) rich oils-fish oil and linseed oil. J Drug Deliv Sci Technol. 2021;63.","journal-title":"J Drug Deliv Sci Technol"},{"key":"9635_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2024.09.031","volume":"92","author":"K Yan","year":"2025","unstructured":"Yan K, Li F, Bi X, Han L, Zhang Z, Chen R, et al. Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2025;92:92\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"9635_CR28","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.5826\/dpc.1501a4838","volume":"15","author":"F Pirro","year":"2025","unstructured":"Pirro F, Caldarola G, Bernardini N, Celeste MG, Dattola A, Luca ED, et al. Risankizumab versus secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy. Dermatol Pract Concept. 2025;15:4838\u20134838.","journal-title":"Dermatol Pract Concept"},{"key":"9635_CR29","doi-asserted-by":"crossref","unstructured":"Ning Q, Yue Y, Liu X, Ji W, Zhao Q, Wang J, et al. Exploring the Therapeutic Effects of Anisole on Psoriasis in Mice Based on the JAK1\/STAT3 Pathway. Phytother Res [Internet]. 2025 [cited 2025 Feb 3];. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ptr.8426","DOI":"10.1002\/ptr.8426"},{"key":"9635_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/md22070300","volume":"22","author":"L Micheli","year":"2024","unstructured":"Micheli L, Vasarri M, Degl\u2019Innocenti D, Di Mannelli CL, Ghelardini C, Emiliano A, et al. Posidonia oceanica (L.) delile is a promising marine source able to alleviate imiquimod-induced psoriatic skin inflammation. Mar Drugs. 2024;22:300.","journal-title":"Mar Drugs"},{"key":"9635_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/DAD.0000000000002648","volume":"46","author":"S Kaya\u00e7etin","year":"2024","unstructured":"Kaya\u00e7etin S, \u00d6calan DT, G\u00fcl \u00dc. Comparison of histopathological findings in psoriasis according to the lesion location from biopsy. Am J Dermatopathol. 2024;46:353.","journal-title":"Am J Dermatopathol"},{"key":"9635_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/jbcpp-2023-0254","volume":"35","author":"O Chatterjee","year":"2024","unstructured":"Chatterjee O, Sur D. Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat. J Basic Clin Physiol Pharmacol. 2024;35:45\u201352.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"9635_CR33","doi-asserted-by":"publisher","first-page":"13113","DOI":"10.2147\/IJN.S492180","volume":"19","author":"ZK Maded","year":"2024","unstructured":"Maded ZK, Lassoued MA, Alrhman TGA, Fawzi HA, Abdulqader AA, Jabir MS, et al. Topical application of dipyridamole and roflumilast combination nanoparticles loaded nanoemulgel for the treatment of psoriasis in rats. Int J Nanomedicine. 2024;19:13113\u201334.","journal-title":"Int J Nanomedicine"},{"key":"9635_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04954-y","volume":"13","author":"A Kumar","year":"2022","unstructured":"Kumar A, Mishra S, Kumar A, Raut AA, Sato S, Takaoka A, et al. Essential role of Rnd1 in innate immunity during viral and bacterial infections. Cell Death Dis. 2022;13:1\u201312.","journal-title":"Cell Death Dis"},{"key":"9635_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41418-024-01269-7","volume":"31","author":"H Jiao","year":"2024","unstructured":"Jiao H, James SJ, Png CW, Cui C, Li H, Li L, et al. DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response. Cell Death Differ. 2024;31:280\u201391.","journal-title":"Cell Death Differ"},{"key":"9635_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11095-023-03648-0","volume":"41","author":"P Dehghani","year":"2024","unstructured":"Dehghani P, Varshosaz J, Mirian M, Minaiyan M, Kazemi M, Bodaghi M. Keratinocyte exosomes for topical delivery of tofacitinib in treatment of psoriasis: an in vitro\/ in vivo study in animal model of psoriasis. Pharm Res. 2024;41:263\u201379.","journal-title":"Pharm Res"},{"key":"9635_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2024.02.007","volume":"114","author":"W Liu","year":"2024","unstructured":"Liu W, Wang Y, Zhang Y, Zhou M, Gu H, Lu M, et al. Rh family C glycoprotein contributes to psoriatic inflammation through regulating the dysdifferentiation and cytokine secretion of keratinocytes. J Dermatol Sci. 2024;114:2\u201312.","journal-title":"J Dermatol Sci"},{"key":"9635_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117867","volume":"326","author":"Y Lin","year":"2024","unstructured":"Lin Y, Yin X, Ma S, Xue Y, Hu C, Xie Y, et al. Cang-ai volatile oil ameliorates imiquimod-induced psoriatic skin lesions by suppressing the ILC3s. J Ethnopharmacol. 2024;326.","journal-title":"J Ethnopharmacol"},{"key":"9635_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117801","volume":"183","author":"M Farooq","year":"2025","unstructured":"Farooq M, Ahmad B, Han JH, Patra MC, Khan AW, Choi H, et al. Rational design and therapeutic potential of MyD88 inhibitory peptide in psoriasis. Biomed Pharmacother. 2025;183.","journal-title":"Biomed Pharmacother"},{"key":"9635_CR40","doi-asserted-by":"publisher","first-page":"e13689","DOI":"10.1111\/srt.13689","volume":"30","author":"F Mohammadi","year":"2024","unstructured":"Mohammadi F, Harofteh FZ, Sahebnasagh A, Ghaneei N, Ardakani MEZ, Saghafi F. Efficacy and safety of topical rosuvastatin & melatonin vs placebo in patients with mild to moderate plaque psoriasis: a preliminary randomized double-blinded clinical trial. Skin Res Technol. 2024;30:e13689.","journal-title":"Skin Res Technol"},{"key":"9635_CR41","unstructured":"Sachdeva M, Patel K. Methods and formulations for topical treatment of psoriasis [Internet]. 2018 [cited 2025 Feb 11]. Available from: https:\/\/patents.google.com\/patent\/US9867827B1\/en"},{"key":"9635_CR42","doi-asserted-by":"crossref","unstructured":"Orro K, Salk K, Abram K, Arshavskaja J, Meikas A, Karelson M, et al. Assessment of soluble skin surface protein levels for monitoring psoriasis vulgaris in adult psoriasis patients using non-invasive transdermal analysis patch: A pilot study. Front Med [Internet]. 2023 [cited 2025 Feb 11];10. Available from: https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2023.1072160\/full","DOI":"10.3389\/fmed.2023.1072160"},{"key":"9635_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.47102\/annals-acadmedsg.2021380","volume":"51","author":"YW Yew","year":"2022","unstructured":"Yew YW, Phuan CZY, Zhao X, Tan EST, Chong W-S, Tey HL. Novel transdermal device for delivery of triamcinolone fornail psoriasis treatment. Ann Acad Med Singapore. 2022;51:16\u201323.","journal-title":"Ann Acad Med Singapore"},{"key":"9635_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/bjd\/ljad188","volume":"189","author":"N Yu","year":"2023","unstructured":"Yu N, Peng C, Zhou J, Gu J, Xu J, Li X, et al. Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis. Br J Dermatol. 2023;189:437\u201346.","journal-title":"Br J Dermatol"},{"key":"9635_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mpdhp.2024.11.005","volume":"31","author":"MT Fernandez-Figueras","year":"2025","unstructured":"Fernandez-Figueras MT, Puig L. Histopathological diagnosis of psoriasis and psoriasiform dermatitides. Diagn Histopathol. 2025;31:87\u201397.","journal-title":"Diagn Histopathol"},{"key":"9635_CR46","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1021\/acsptsci.4c00152","volume":"7","author":"H Ridha-Salman","year":"2024","unstructured":"Ridha-Salman H, Shihab EM, Hasan HK, Abbas AH, Khorsheed SM, Ayad FS. Mitigative effects of topical norfloxacin on an imiquimod-induced murine model of psoriasis. ACS Pharmacol Transl Sci. 2024;7:2739\u201354.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"9635_CR47","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3390\/ijms24076111","volume":"24","author":"CSB Andersen","year":"2023","unstructured":"Andersen CSB, Kvist-Hansen A, Siewertsen M, Enevold C, Hansen PR, Kaur-Knudsen D, et al. Blood cell biomarkers of inflammation and cytokine levels as predictors of response to biologics in patients with psoriasis. Int J Mol Sci. 2023;24:6111.","journal-title":"Int J Mol Sci"},{"key":"9635_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.abd.2023.03.002","volume":"99","author":"MNR de Alves","year":"2024","unstructured":"de Alves MNR, Kurizky PS, da Mota LMH, de Albuquerque CP, Esper JT, Campos ASC, et al. Elevated serum IL-6 levels predict treatment interruption in patients with moderate to severe psoriasis: a 6-year real-world cohort study. An Bras Dermatol. 2024;99:34\u201342. https:\/\/doi.org\/10.1016\/j.abd.2023.03.002.","journal-title":"An Bras Dermatol"},{"key":"9635_CR49","doi-asserted-by":"publisher","first-page":"E180324228068","DOI":"10.2174\/0115701638278470240312075112","volume":"22","author":"K Abhale","year":"2025","unstructured":"Abhale K, Veeranjaneyulu A, Desai S. A snapshot of biomarkers in psoriasis. Curr Drug Discov Technol. 2025;22:E180324228068.","journal-title":"Curr Drug Discov Technol"},{"key":"9635_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12865-024-00630-2","volume":"25","author":"FZ Kamel","year":"2024","unstructured":"Kamel FZ, Hoseiny HAM, Shahawy AAE, Boghdadi G, Shahawy AAE. NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis. BMC Immunol. 2024;25:40.","journal-title":"BMC Immunol"},{"key":"9635_CR51","doi-asserted-by":"publisher","unstructured":"Lv Y, Xu Y, Liu S, Zeng X, Biochanin YB, Attenuates A, psoriasiform inflammation by regulating Nrf2, HO-1 pathway activation and attenuating inflammatory signalling. Cell Biochem Biophys [Internet]. 2024 [cited 2025 Feb 11] Available from: https:\/\/doi.org\/10.1007\/s12013-024-01595-0.","DOI":"10.1007\/s12013-024-01595-0"},{"key":"9635_CR52","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"H-J Lee","year":"2023","unstructured":"Lee H-J, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023;24:13313.","journal-title":"Int J Mol Sci"},{"key":"9635_CR53","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1016\/j.apsb.2024.08.013","volume":"14","author":"C Wu","year":"2024","unstructured":"Wu C, Yu Q, Huang C, Li F, Zhang L, Zhu D. Microneedles as transdermal drug delivery system for enhancing skin disease treatment. Acta Pharm Sin B. 2024;14:5161\u201380.","journal-title":"Acta Pharm Sin B"},{"key":"9635_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102364","volume":"62","author":"SL Jyothi","year":"2021","unstructured":"Jyothi SL, Krishna KL, Ameena Shirin VK, Sankar R, Pramod K, Gangadharappa HV. Drug delivery systems for the treatment of psoriasis: current status and prospects. J Drug Deliv Sci Technol. 2021;62.","journal-title":"J Drug Deliv Sci Technol"},{"key":"9635_CR55","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9:1511.","journal-title":"Biomedicines"},{"key":"9635_CR56","doi-asserted-by":"publisher","first-page":"1759720X1988397","DOI":"10.1177\/1759720X19883973","volume":"11","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG, Chapurlat RD, Gua\u00f1abens N, Haugeberg G, Lems WF, et al. Balancing benefits and risks in the era of biologics. Ther Adv Musculoskelet Dis. 2019;11:1759720X19883973.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"9635_CR57","doi-asserted-by":"publisher","first-page":"1542453","DOI":"10.3389\/fphar.2024.1542453","volume":"15","author":"I Convertino","year":"2025","unstructured":"Convertino I, Lopes LC, Pratt N, Ingrasciotta Y, Tuccori M. Editorial: biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world. Front Pharmacol. 2025;15:1542453.","journal-title":"Front Pharmacol"},{"issue":"9","key":"9635_CR58","doi-asserted-by":"publisher","first-page":"e29518","DOI":"10.7759\/cureus.29518","volume":"14","author":"KM Hamed","year":"2022","unstructured":"Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022;14(9):e29518.https:\/\/doi.org\/10.7759\/cureus.29518","journal-title":"Cureus"},{"key":"9635_CR59","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/acsbiomaterials.3c01810","volume":"10","author":"P Zhao","year":"2024","unstructured":"Zhao P, Li Z, Ling Z, Zheng Y, Chang H. Efficient loading and sustained delivery of methotrexate using a tip-swellable microneedle array patch for psoriasis treatment. ACS Biomater Sci Eng. 2024;10:921\u201331.","journal-title":"ACS Biomater Sci Eng"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09635-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:02:22Z","timestamp":1770192142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09635-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9635"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09635-4","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were conducted in accordance with ethical guidelines and regulations set by Institutional Animal Ethics Committee (IAEC). Approval for this study was obtained from the IAEC of NIMS University Rajasthan, under protocol number NIMSUR\/IAEC\/01\/2022\/04. All efforts were made to minimize animal suffering, and experimental procedures were performed following the principles outlined in the Guide for the Care and Use of Laboratory Animals and in compliance with national and institutional regulations. Animals were housed in a controlled environment with standard food and water access, and human endpoints were established to ensure their well-being.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}